Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Phase 3 - Partnering Implications
View:
Post by Harper75 on May 26, 2021 9:20am

Phase 3 - Partnering Implications

Perhaps a change in thread...

Antibe hasn't been shy about courting a Phs3 Partner, we all also talk about it.

Any thoughts to the implications on who Antibe eventually partners with?  Is the market assuming that one of the giants will step up and if they do not, is that seen as a negative catalyst.  Is there any partnering baked into the SP right now?
Comment by GameChangerBet on May 26, 2021 12:25pm
[/quote The concentration is now on Europe and the US, with Japan soon. They are a week away from finishing the contacting of the names on their target list for Europe/US. I would argue that no pricing in of any potential partnerships has occured in the stock. Which really leaves the runway wide open for a big price move and revaluation.
Antibe Therapeutics Inc(Pre-Merger)